다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Bionano Genomics Inc (BNGO)
Bionano Genomics Inc (BNGO) 뉴스

BNGO

Bionano Genomics (BNGO)

Bionano Genomics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BNGO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	21:00	GlobeNewswire Inc.	Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/28	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/28	21:00	GlobeNewswire Inc.	Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/21	21:00	GlobeNewswire Inc.	Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	21:00	GlobeNewswire Inc.	Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	06:27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	05:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	05:01	GlobeNewswire Inc.	Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/01	21:00	GlobeNewswire Inc.	Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/01	05:05	GlobeNewswire Inc.	Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/24	21:00	GlobeNewswire Inc.	Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/17	21:00	GlobeNewswire Inc.	Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/11	21:00	GlobeNewswire Inc.	Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/05	02:44	GlobeNewswire Inc.	Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/03	21:00	GlobeNewswire Inc.	Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/02	21:00	GlobeNewswire Inc.	Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/19	21:00	GlobeNewswire Inc.	Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/07	22:00	GlobeNewswire Inc.	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07:26	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	06:01	GlobeNewswire Inc.	Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/29	22:00	GlobeNewswire Inc.	Bionano to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22:01	GlobeNewswire Inc.	Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22:00	GlobeNewswire Inc.	Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway	NASDAQ:BNGO	Bionano Genomics Inc

검색 관련기사 보기:NASDAQ:BNGO

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관